We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FIS:NYSEFidelity National Information Services, Inc. Analysis

Data as of 2026-03-10 - not real-time

$50.13

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Fidelity National Information Services is trading well below its 20‑day and 50‑day moving averages, signaling a short‑term bearish bias, while the MACD histogram remains modestly bullish, suggesting a potential near‑term rebound. Fundamentally, the stock’s price‑to‑earnings multiple is markedly higher than the industry average, and the DCF‑derived fair value sits below the current market price, indicating the shares are overvalued at present. Volatility is elevated, exceeding 40% over the past month, but the beta is under one, reflecting lower systematic market risk. Recent earnings missed consensus expectations, yet analysts have maintained a buy rating, citing the company’s 8% revenue growth and a new AI‑driven Insurance Risk Suite that could unlock future upside. The dividend yield appears attractive, but a payout ratio well above 100% raises concerns about sustainability.
Overall, the blend of high valuation multiples, strong cash generation, and strategic AI initiatives creates a nuanced outlook: short‑term pressure from technical weakness and valuation stretch, balanced by medium‑ to long‑term growth potential if the AI products gain traction and the company can improve profitability and deleverage its balance sheet.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Technical bearish trend despite modest MACD bullishness
  • Current valuation above fair value

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Analyst consensus remains positive
  • Revenue growth and AI product rollout
  • Elevated valuation but improving cash flow

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic AI initiatives expanding addressable market
  • Potential for margin improvement and debt reduction
  • Dividend yield attractive if payout ratio normalizes

Key Metrics & Analysis

Financial Health

Revenue Growth8.20%
Profit Margin3.58%
P/E Ratio68.7
ROE2.60%
ROA4.37%
Debt/Equity95.89
P/B Ratio1.9
Op. Cash Flow$2.8B
Free Cash Flow$1.9B
Industry P/E37.1

Technical Analysis

TrendBearish
RSI42.6
Support$46.16
Resistance$51.82
MA 20$49.38
MA 50$56.31
MA 200$67.61
MACDBullish
VolumeStable
Fear & Greed Index80.5

Valuation

Fair Value$46.86
Target Price$66.82
Upside/Downside33.29%
GradeOvervalued
TypeBlend
Dividend Yield3.18%

Risk Assessment

Beta0.72
Volatility42.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.